NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
RILABNACEPT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
9
Latest update
12/03/2024
Trademark type
Word
Nice classes
5
Filing date
01/09/2024
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Dist Hangzhou, CN
Examiner
FIRST, VIVIAN M
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Hangzhou Gene-based Biopharmaceutical Co., Ltd.
Representatives
Roman Campos Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-inflammatory and antipyretic preparations; Anti-inflammatory preparations; Chemical reagents for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes
Publications
History of USPTO decisions and trademark events.
9 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2024
PUBO
PUBLISHED FOR OPPOSITION
09/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2024
DOCK
ASSIGNED TO EXAMINER
08/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2024
NWAP
NEW APPLICATION ENTERED
01/09/2024
Continuous trademark protection
Get notified about every new filing that threatens RILABNACEPT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.